PPC
CTSO icon

Park Place Capital’s Cytosorbents Corp CTSO Stock Holding History

Park Place Capital’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-781
Closed -$1.47K – 910
2023
Q3 		$1.47K Hold
781
– – ﹤0.01% 953
2023
Q2 		$2.8K Hold
781
– – ﹤0.01% 916
2023
Q1 		$2.63K Buy
781
+291
+59% +$873 ﹤0.01% 922
2022
Q4 		$1K Buy
+490
New +$727 ﹤0.01% 990

Other funds holding CTSO

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Park Place Capital's CTSO Position: Q4 2023 in Review

Park Place Capital sold out of Cytosorbents Corp (CTSO) in Q4 2023, closing a stake of 781 shares — an estimated $1.47K sold.

Park Place Capital first reported a position in CTSO in Q4 2022 and held it in 4 quarters. The position peaked at $2.8K in Q2 2023. 54 funds tracked by Wall St. Rank hold CTSO as of Q4 2023.

  • Park Place Capital reported no remaining Cytosorbents Corp position as of Q4 2023 after selling out during the quarter.
  • Park Place Capital sold 781 Cytosorbents Corp shares in Q4 2023, an estimated $1.47K.
  • Park Place Capital first reported a position in Cytosorbents Corp in Q4 2022 and held it in 4 quarters.
  • Park Place Capital's Cytosorbents Corp position peaked at $2.8K in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2023.

Based on Park Place Capital's 13F filing for Q4 2023, filed 24 Jan 2024.